Intellia Therapeutics, Inc. (NTLA)
12.26
+0.14
(+1.16%)
USD |
NASDAQ |
Oct 02, 16:00
12.16
-0.10
(-0.82%)
After-Hours: 20:00
Intellia Therapeutics Profit Margin (Quarterly) : -1.39K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.39K% |
| March 31, 2026 | -639.5% |
| December 31, 2025 | -416.2% |
| September 30, 2025 | -735.2% |
| June 30, 2025 | -710.8% |
| March 31, 2025 | -687.6% |
| December 31, 2024 | -1.00K% |
| September 30, 2024 | -1.49K% |
| June 30, 2024 | -2.11K% |
| March 31, 2024 | -371.3% |
| December 31, 2023 | |
| September 30, 2023 | -1.02K% |
| June 30, 2023 | -909.8% |
| March 31, 2023 | -818.1% |
| December 31, 2022 | -835.5% |
| September 30, 2022 | -853.5% |
| June 30, 2022 | -717.6% |
| March 31, 2022 | -1.31K% |
| December 31, 2021 | -632.0% |
| September 30, 2021 | -994.5% |
| June 30, 2021 | -1.05K% |
| Date | Value |
|---|---|
| March 31, 2021 | -716.9% |
| December 31, 2020 | -639.8% |
| September 30, 2020 | -125.3% |
| June 30, 2020 | -199.2% |
| March 31, 2020 | -246.3% |
| December 31, 2019 | -258.6% |
| September 30, 2019 | -222.6% |
| June 30, 2019 | -231.0% |
| March 31, 2019 | -210.3% |
| December 31, 2018 | -242.0% |
| September 30, 2018 | -306.5% |
| June 30, 2018 | -289.4% |
| March 31, 2018 | -285.9% |
| December 31, 2017 | -359.4% |
| September 30, 2017 | -209.9% |
| June 30, 2017 | -263.5% |
| March 31, 2017 | -203.2% |
| December 31, 2016 | -187.7% |
| September 30, 2016 | -153.7% |
| June 30, 2016 | -164.1% |
| March 31, 2016 | -376.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -25.04K% |
| Twist Bioscience Corp. | -29.61% |
| Prime Medicine, Inc. | -3.65K% |
| Moderna, Inc. | -539.3% |
| Q32 Bio, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.41% |
| Return on Assets | -46.70% |
| Return on Invested Capital | -50.87% |
| Gross Profit Margin (Quarterly) | 72.58% |
| Operating Margin (Quarterly) | -1.47K% |
| Return on Net Operating Assets | -260.4% |